Stay updated on Dapagliflozin in Chronic Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Chronic Heart Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Chronic Heart Failure Clinical Trial page
- Check3 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer. The changes are limited to meta/version notes and do not alter study data or user functionality.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedAdded revision label v3.3.2 and removed v3.2.0 from the page history header. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedThe government funding/operating-status notice in the header was removed. It previously directed users to cc.nih.gov and opm.gov for status updates, and its removal leaves only the standard page content.SummaryDifference0.5%

- Check53 days agoChange DetectedNew screenshot shows minor visual adjustments to headers and spacing on the Record History page, with no new content or version changes.SummaryDifference0.1%

- Check82 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse with current operating status and a v3.2.0 revision. This indicates a status update and new version release, with important details about openness of NIH Clinical Center and where to check operating status.SummaryDifference10%

- Check89 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.2%

Stay in the know with updates to Dapagliflozin in Chronic Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Chronic Heart Failure Clinical Trial page.